Long-acting injectable agents for HIV prevention may offer adherence advantages over daily oral agents if proven safe, acceptable and efficacious. This paper describes the possible benefits and unique complexities associated with these novel agents.
The promise and pitfalls of long-acting injectable agents for HIV prevention
Written By
Landovitz RJ, Kofron R, McCauley M.
